Literature DB >> 2424930

High frequency of immune dysfunctions in asbestos workers and in patients with malignant mesothelioma.

F Lew, P Tsang, J F Holland, N Warner, I J Selikoff, J G Bekesi.   

Abstract

We have examined the primary immune responses, the numbers of total T (T11+) cells, T-helper (T4+) cells, T-suppressor (T8+) cells, and natural killer (NK) (Leu7+) cells, in 118 healthy control subjects and compared the data to those obtained from 20 patients with clinically diagnosed malignant mesothelioma and 375 long-term asbestos workers without neoplasia. The absolute numbers of total T (T11+) and T-helper (T4+) cells were normal in asbestos workers without neoplasia but were significantly reduced in patients with mesothelioma. T-suppressor (T8+) cells, on the other hand, remained unchanged in the patients but were significantly elevated among the asbestos workers. This resulted in a marked reduction in T-helper (Th) to T-suppressor (Ts) ratios in mesothelioma patients and in asbestos workers. Seventy percent of the mesothelioma patients (14 of 20) had significantly depressed NK-cell activity which could be augmented but not normalized by coincubation in patients' peripheral blood lymphocytes (PBL) with interferon (IFN). Among the asbestos workers three distinctive subgroups could be identified: heightened (H-NK), normal (N-NK), and low (L-NK) NK activity. The NK activity of the L-NK group could be stimulated but not normalized by coincubation with IFN, a finding closely resembling that in malignant mesothelioma patients. Phenotyping of the circulating NK cells revealed a unique Leu7+ subset in increased numbers with a brightly fluorescent property in stable mesothelioma patients with relatively stable or slowly progressive disease and in more than 30% of the asbestos workers.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424930     DOI: 10.1007/bf00918702

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  26 in total

1.  Phenotypic and functional correlations in circulating lymphocytes of prodromal homosexuals and patients with AIDS.

Authors:  P H Tsang; N Warner; J G Bekesi
Journal:  J Clin Lab Immunol       Date:  1985-05

2.  Rheumatoid factor in serum of individuals exposed to asbestos.

Authors:  B Pernis; E C Vigliani; I J Selikoff
Journal:  Ann N Y Acad Sci       Date:  1965-12-31       Impact factor: 5.691

3.  Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity.

Authors:  E Kagan; A Solomon; J C Cochrane; P Kuba; P H Rocks; I Webster
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

4.  Humoral immunologic abnormalities in workers exposed to asbestos cement dust.

Authors:  N J Doll; J E Diem; R N Jones; M Rodriguez; B E Bozelka; R P Stankus; H Weill; J E Salvaggio
Journal:  J Allergy Clin Immunol       Date:  1983-11       Impact factor: 10.793

5.  Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects.

Authors:  F Lew; P Tsang; S Solomon; I J Selikoff; J G Bekesi
Journal:  J Clin Lab Immunol       Date:  1984-07

6.  Circulating immune complexes and antiglobulins (IgG and IgM) in asbestos-induced lung fibrosis.

Authors:  A Lange; L J Nineham; D Garncarek; R Smolik
Journal:  Environ Res       Date:  1983-08       Impact factor: 6.498

7.  The follow-up study of skin reactivity to recall antigens and E- and EAC-RFC profiles in blood in asbestos workers.

Authors:  A Lange; G Skibiński; D Garncarek
Journal:  Immunobiology       Date:  1980-04       Impact factor: 3.144

8.  The interferon system in patients with malignant disease.

Authors:  T Hahn; S Levin
Journal:  J Interferon Res       Date:  1982

9.  Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Authors:  A H Rook; H Masur; H C Lane; W Frederick; T Kasahara; A M Macher; J Y Djeu; J F Manischewitz; L Jackson; A S Fauci; G V Quinnan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

10.  Modulation of T- and B-lymphocyte functions by isoprinosine in homosexual subjects with prodromata and in patients with acquired immune deficiency syndrome (AIDS).

Authors:  P H Tsang; K Tangnavarad; S Solomon; J G Bekesi
Journal:  J Clin Immunol       Date:  1984-11       Impact factor: 8.317

View more
  6 in total

1.  Lymphocyte subsets in subjects exposed to asbestos: changes in circulating natural killer cells.

Authors:  N al Jarad; M Macey; S Uthayakumar; A C Newland; R M Rudd
Journal:  Br J Ind Med       Date:  1992-11

Review 2.  What's the place of immunotherapy in malignant mesothelioma treatments?

Authors:  Marc Grégoire
Journal:  Cell Adh Migr       Date:  2010-01-30       Impact factor: 3.405

Review 3.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

Review 4.  Novel therapies in phase II and III trials for malignant pleural mesothelioma.

Authors:  Marjorie G Zauderer; Lee M Krug
Journal:  J Natl Compr Canc Netw       Date:  2012-01       Impact factor: 11.908

Review 5.  Nonpulmonary outcomes of asbestos exposure.

Authors:  Melisa Bunderson-Schelvan; Jean C Pfau; Robert Crouch; Andrij Holian
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

6.  One-year follow-up of the phagocytic activity of leukocytes after exposure of rats to asbestos and basalt fibers.

Authors:  M Hurbánková
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.